OP
BEAM icon

ORG Partners’s Beam Therapeutics BEAM Stock Holding History

ORG Partners’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$693 Buy
+25
New +$638 ﹤0.01% 1594
2025
Q3 		– Sell
-30
Closed -$525 – 1597
2025
Q2 		$525 Sell
30
-26
-46% -$453 ﹤0.01% 1402
2025
Q1 		$987 Buy
+56
New +$1.47K ﹤0.01% 1175

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ORG Partners's BEAM Position: Q4 2025 in Review

ORG Partners opened a new position in Beam Therapeutics (BEAM) in Q4 2025: 25 shares worth $693. The stake represents ﹤0.01% of the portfolio and ranks #1594 among its holdings. This is a return to the name: ORG Partners previously reported a position in BEAM as recently as Q2 2025.

ORG Partners first reported a position in BEAM in Q1 2025 and has held it in 3 quarters since. The position peaked at $987 in Q1 2025. 246 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.

  • ORG Partners held 25 shares of Beam Therapeutics worth $693 as of Q4 2025.
  • Beam Therapeutics was a new ORG Partners position in Q4 2025.
  • Beam Therapeutics made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1594 holding.
  • ORG Partners first reported a position in Beam Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • ORG Partners's Beam Therapeutics position peaked at $987 in Q1 2025.
  • 246 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.